Recombinant Human Anti-OR9Q2 Soluble TCR (LA6) (C-Cys) (CAT#: VS-0622-YF4789)
Human TCR (LA6) recognizes OR9Q2 peptide (FIDCYLLAI) in the context of HLA-A2. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- OR9Q2
- Epitope
- FIDCYLLAI
- MHC
- HLA-A2
- Clone
- LA6
- Type
- Soluble TCR (C-Cys)
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- Olfactory Receptor Family 9 Subfamily Q Member 2 variant SID_S1F; FIDCYLLAI
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone LA6"
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF4789. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: ELISA, IP, FC, FuncS, Neut, IF, WB
Application: ELISA, IP, FC, FuncS, Neut, IF, IHC
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: WB, ELISA, Neut, FuncS
Application: Neut, ELISA, FuncS
Application: ELISA, FuncS
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
